$0.0747
0[0.00%]
At close: Mar 4
Bellicum Pharmaceuticals Inc
(OTC:BLCM)Bellicum Pharmaceuticals Inc Stock (OTC:BLCM), Earnings Estimates, EPS, and Revenue
Bellicum Pharmaceuticals Inc reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.020
Quarterly Revenue
$1M
Annual Revenue
–
Analyze the earnings history of Bellicum Pharmaceuticals Inc using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | PM | BLCM | Q1 | -$0.26 | — | — | — | $8.00K | — | — | — | Get Alert |
| 04/30/2024 | PM | BLCM | Q4 | -$0.20 | — | — | — | $500.00K | — | — | — | Get Alert |
| 11/14/2023 | PM | BLCM | Q3 | -$0.23 | — | -$0.02 | — | $1.00M | — | $1.00M | — | Get Alert |
| 08/10/2023 | PM | BLCM | Q2 | -$0.13 | — | -$0.24 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/11/2023 | PM | BLCM | Q1 | -$0.25 | — | -$0.26 | — | $0.00 | — | $8.00K | — | Get Alert |
| 03/31/2023 | PM | BLCM | Q4 | $0.11 | -$0.93 | -$0.20 | 78.49% | $500.00K | — | $500.00K | — | Get Alert |
| 11/10/2022 | PM | BLCM | Q3 | $0.07 | -$0.64 | -$0.23 | 64.06% | $5.00M | — | $1.00M | — | Get Alert |
| 08/11/2022 | PM | BLCM | Q2 | -$0.22 | -$0.69 | -$0.13 | 81.16% | $700.00K | — | $0.00 | — | Get Alert |
| 05/12/2022 | PM | BLCM | Q1 | -$1.12 | — | -$0.25 | — | $0.00 | — | $0.00 | — | Get Alert |
| 03/24/2022 | PM | BLCM | Q4 | $0.98 | — | $0.11 | — | $500.00K | — | $500.00K | — | Get Alert |
| 11/04/2021 | PM | BLCM | Q3 | -$0.18 | — | $0.07 | — | $0.00 | — | $5.00M | — | Get Alert |
| 08/12/2021 | PM | BLCM | Q2 | -$7.81 | -$1.37 | -$0.22 | 83.94% | $0.00 | $250.00K | $700.00K | 180.00% | Get Alert |
| 05/17/2021 | AM | BLCM | Q1 | $1.09 | — | -$1.08 | — | $0.00 | — | $0.00 | — | Get Alert |
| 03/30/2021 | PM | BLCM | Q4 | -$5.82 | -$1.06 | $1.14 | 207.55% | $133.00K | $250.00K | $500.00K | 100.00% | Get Alert |
| 11/05/2020 | PM | BLCM | Q3 | -$6.80 | — | -$0.18 | — | $103.00K | — | $0.00 | — | Get Alert |
| 08/06/2020 | PM | BLCM | Q2 | -$5.80 | -$3.33 | -$7.81 | -134.53% | $1.39M | $900.00K | $0.00 | -100.00% | Get Alert |
| 05/07/2020 | PM | BLCM | Q1 | -$5.50 | — | $1.09 | — | $516.00K | — | $0.00 | — | Get Alert |
| 03/12/2020 | PM | BLCM | Q4 | -$6.30 | -$4.00 | -$5.82 | -45.50% | $312.00K | $630.00K | $133.00K | -78.89% | Get Alert |
| 11/06/2019 | PM | BLCM | Q3 | -$5.50 | -$5.30 | -$6.80 | -28.30% | $292.00K | $1.20M | $103.00K | -91.42% | Get Alert |
FAQ
When is Bellicum Pharmaceuticals Inc (OTC:BLCM) reporting earnings?
Bellicum Pharmaceuticals Inc (BLCM) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on November 14, 2023 for Q3.
What were the latest earnings per share (EPS) for Bellicum Pharmaceuticals Inc (OTC:BLCM)?
The Actual EPS was $-0.02, which missed the estimate of $0.00.
What were Bellicum Pharmaceuticals Inc’s (OTC:BLCM) revenues?
The Actual Revenue was $1M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.